Investigators may unlock mystery of how staph cells dodge the body's immune system

September 21, 2017
Four spherical MRSA bacteria being enveloped and destroyed by human white blood cells. Credit: National Institute of Allergy and Infectious Diseases (NIAID)

For years, medical investigators have tried and failed to develop vaccines for a type of staph bacteria associated with the deadly superbug MRSA. But a new study by Cedars-Sinai investigators shows how staph cells evade the body's immune system, offering a clearer picture of how a successful vaccine would work.

Staph frequently causes skin infections but occasionally can lead to deadly conditions such as sepsis, pneumonia and bloodstream infections, particularly in hospitalized patients whose immune systems could be weakened by illness.

One strain of the bacterium, the superbug methicillin-resistant Staphylococcus aureus (MRSA), is considered one of the top drug-resistant threats in the U.S., causing more than 11,000 deaths per year, according to the Centers for Disease Control and Prevention. In fact, the superbug kills more Americans than HIV.

"Widespread MRSA infections have prompted routine use of once last-line antibiotics, and this is making the antibiotic resistance problem worse," said George Liu, MD, PhD, co-lead author of the study and a pediatric infectious diseases physician at Cedars-Sinai's Maxine Dunitz Children's Health Center and the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute. "Our study focuses on why MRSA is so common and why we never develop immunity to these bacteria."

The study, published in the peer-reviewed journal Cell Host & Microbe, also sheds light on how investigators could develop an effective vaccine against staph.

When exposed to a pathogen like a staph bacterium, the body usually fights it and then forms a memory of how its immune system responded. The next time the body encounters the same pathogen, it can use that memory to fight off the microbe much more easily.

But the body can suffer from repeated throughout life without developing a robust protective memory immune response. The study shows that are able to dodge this immune response.

When the staph cell wall primarily is kept intact after infecting a host, bacterial molecules don't escape the staph cell and the body isn't prompted to produce robust protective immune memory.

"Essentially, staph tricks the body's T cells, which are white blood cells that fight , and prevents them from mounting an effective defense," said co-lead author Gislaine Martins, PhD, an assistant professor at the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute and departments of Biomedical Science and Medicine.

As a result, the body does not develop long-term immunity and remains vulnerable to that particular staph infection throughout life. While certain staph bacteria cause mild skin infections, other strains of staph bacteria can wreak havoc in the bloodstream and bones, sometimes leading to amputations.

"The study explains why our immune system is fooled by staph," Martins said. "Staph evolved to have this enzyme that makes this modification in its cell wall. This modification protects the wall from degradation and therefore from being properly detected by the immune system, which won't remember the bacteria the next time the body is infected."

When study authors removed the cell wall modification, the staph cells spilled their molecules more easily. The modified sparked a robust memory immune response that protected against reinfection.

The study provides clues about what type of element could be added to staph vaccines to make them more effective. Whereas most vaccines have tried to stimulate antibodies—specialized molecules that recognize foreign bodies and help to mobilize the immune system—this study suggests that a successful vaccine should harness the 's T .

Explore further: Excess dietary manganese promotes staph heart infection

More information: Cell Host & Microbe (2017). DOI: 10.1016/j.chom.2017.08.008

Related Stories

Excess dietary manganese promotes staph heart infection

September 21, 2017
Too much dietary manganese—an essential trace mineral found in leafy green vegetables, fruits and nuts—promotes infection of the heart by the bacterium Staphylococcus aureus ("staph").

New vaccine protects against lethal pneumonia caused by staph bacteria

December 20, 2013
University of Iowa researchers have developed a new vaccine that protects against lethal pneumonia caused by Staphylococcus aureus (staph) bacteria, including drug-resistant strains like MRSA.

New research raises questions about using certain antibiotics to treat 'superbug' MRSA

November 11, 2015
A new study sheds light on how treatment of the "superbug" known as MRSA with certain antibiotics can potentially make patients sicker. The findings by Cedars-Sinai scientists, published today in the journal Cell Host & Microbe, ...

How Staph infections elude the immune system

October 27, 2014
A potentially lethal bacterium protects itself by causing immune tunnel vision, according to a study from scientists at The University of Chicago published in The Journal of Experimental Medicine. By tricking the immune system ...

Recommended for you

Study seeks to aid diagnosis, management of catatonia

December 11, 2017
Catatonia, a syndrome of motor, emotional and behavioral abnormalities frequently characterized by muscular rigidity and a trance-like mental stupor and at times manifesting with great excitement or agitation, can occur during ...

New compound stops progressive kidney disease in its tracks

December 7, 2017
Progressive kidney diseases, whether caused by obesity, hypertension, diabetes, or rare genetic mutations, often have the same outcome: The cells responsible for filtering the blood are destroyed. Reporting today in Science, ...

New Lyme disease tests could offer quicker, more accurate detection

December 7, 2017
New tests to detect early Lyme disease - which is increasing beyond the summer months -could replace existing tests that often do not clearly identify the infection before health problems occur.

Spinal tap needle type impacts the risk of complications

December 6, 2017
The type of needle used during a lumbar puncture makes a significant difference in the subsequent occurrence of headache, nerve irritation and hearing disturbance in patients, according to a study by Hamilton medical researchers.

Men with HPV are 20 times more likely to be reinfected after one year

December 5, 2017
A new analysis of genital human papillomavirus (HPV) in men shows that infection with one HPV type strongly increases the risk of reinfection with the same type. In fact, men who are infected with the type responsible for ...

New tuberculosis drugs possible with understanding of old antibiotic

December 5, 2017
Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the University of Warwick and The Francis Crick Institute.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.